Q2 2026 saw 4% sales growth and strong cash flow, despite margin pressure from higher raw material costs and startup expenses. Medical Solutions led growth, while Engineered Solutions excelled in materials. Margin recovery and continued expansion are expected.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.